August 10th, 2023

Shares of Vistagen Therapeutics, Inc. (Nasdaq: VTGN) surged over 20% in after-hours trading as Commodore Capital LP disclosed in a regulatory filing (Form 4) with the SEC that it has recently acquired 775,756 shares of Vistagen through multiple trans. Read more

August 09th, 2023

AppLovin Corporation (Nasdaq: APP) reported second quarter 2023 earnings of $0.22 per share, surpassing the consensus EPS estimate of $0.07. Additionally, the company achieved quarterly sales of $750.16 million, exceeding the analysts' forecasted rev. Read more

August 09th, 2023

Shares of Galera Therapeutics, Inc.? (Nasdaq: GRTX) plunged over 70% in after-hours trading as the company received a Complete Response Letter (CRL) from the FDA, addressing its New Drug Application (NDA) for avasopasem manganese, a potential treatme. Read more

August 09th, 2023

In a strategic move to bolster cybersecurity, the Biden-Harris Administration has introduced the "AI Cyber Challenge" (AIxCC), a two-year competition focused on fortifying critical software using artificial intelligence (AI). Led by DARPA and joined . Read more

August 09th, 2023

Shares of Carvana Co. (NYSE: CVNA) surged over 5% in pre-market trading following its announcement of an enhanced Q3 2023 outlook. The improvement is attributed to significant advancements in key business drivers and strong early-quarter momentum. . Read more

August 09th, 2023

GoodRx Holdings, Inc. (Nasdaq: GDRX) revealed second-quarter 2023 adjusted earnings of $0.07 per share, surpassing the consensus EPS estimate of $0.06. The company's quarterly sales amounted to $189.70 million, slightly exceeding the analysts' projec. Read more

August 09th, 2023

Cybersecurity firm Rapid7, Inc. (Nasdaq: RPD) released its second-quarter 2023 financial report, disclosing earnings of $0.18 per share, exceeding the consensus EPS estimate of $0.11. The company's quarterly sales amounted to $190.42 million, slightl. Read more

August 09th, 2023

Array Technologies, Inc. (Nasdaq: ARRY) unveiled its second-quarter 2023 financial report, revealing earnings of $0.47 per share, surpassing the consensus EPS estimate of $0.18. The company's quarterly sales reached $507.70 million, exceeding the ana. Read more

August 08th, 2023

Rocket Lab USA, Inc. (Nasdaq: RKLB) reported a second-quarter 2023 loss of $0.10 per share, which was slightly worse than the consensus estimate of a loss of $0.09 per share. However, revenues for the quarter totaled $62.05 million, slightly exceedin. Read more

August 08th, 2023

Firms admit to wrongdoing and agree to pay penalties totaling $289 million FOR IMMEDIATE RELEASE 2023-149 Washington D.C. / CRWE PRESS RELEASE / Aug. 8, 2023 -  The Securities and Exchange Commission today announced charges against 1. Read more